Breast implant manufacturer Allergan Inc. instigated a recall worldwide for its textured breast implant model after findings of breast implant-caused cancer. The FDA states studies revealed Allergan’s Biocell breast implant was tied to cases of a rare lymphoma, with 80% of the over 500 confirmed lymphoma cases being tied to the Allergan implants.

CBS News revealed that while Biocell implant’s textured surface prevented slipping, therefore reducing scar tissue, these specific textured implants can cause lymphoma to grow in the scar tissue surrounding breasts. This form of lymphoma, known as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), can be treated through surgery. But if not treated quickly, extensive patient harm and death can result from this form of lymphoma.

Currently, the FDA does not recommended women with the implants to have them removed if they are not having any side effects or problems. However, these breast implants make up 5% of the breast implant market in the U.S., so thousands just in the U.S. could be impacted by the recall.

If you received an Allergen textured breast implant and were diagnosed with breast-implant associated anaplastic large cell lymphoma, do not suffer in silence. Contact AVA Law today to be connected with expert personal injury lawyers who will aggressively fight for your right to healing and compensation.

Sources

CBS/AP. "Breast Implants Tied to Rare Form of Cancer Recalled at FDA Request." CBS News. July 24, 2019. Accessed July 24, 2019. https://www.cbsnews.com/news/breast-implant-recall-allergan-recalls-textured-implant-linked-to-rare-cancer-today-2019-07-24/.

Commissioner, Office Of the. "FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders   from Market." U.S. Food and Drug Administration. July 24, 2019.